[HTML][HTML] Transmembrane TNF and its receptors TNFR1 and TNFR2 in mycobacterial infections

A Ruiz, Y Palacios, I Garcia… - International journal of …, 2021 - mdpi.com
Tumor necrosis factor (TNF) is one of the main cytokines regulating a pro-inflammatory
environment. It has been related to several cell functions, for instance, phagocytosis …

Self-assembling peptides as immunomodulatory biomaterials

A Hernandez, JD Hartgerink, S Young - Frontiers in bioengineering …, 2023 - frontiersin.org
Self-assembling peptides are a type of biomaterial rapidly emerging in the fields of
biomedicine and material sciences due to their promise in biocompatibility and effectiveness …

Application of built-in adjuvants for epitope-based vaccines

Y Lei, F Zhao, J Shao, Y Li, S Li, H Chang, Y Zhang - PeerJ, 2019 - peerj.com
Several studies have shown that epitope vaccines exhibit substantial advantages over
conventional vaccines. However, epitope vaccines are associated with limited immunity …

Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers

C Mora-Solano, Y Wen, H Han, J Chen, AS Chong… - Biomaterials, 2017 - Elsevier
Active immunotherapies raising antibody responses against autologous targets are
receiving increasing interest as alternatives to the administration of manufactured …

From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment

N Zhang, M Li, Z Hou, L Ma, A Younas, Z Wang… - Journal of Controlled …, 2022 - Elsevier
Rheumatoid arthritis (RA) is a joint-related autoimmune disease that is difficult to cure. Most
therapeutics act to alleviate the symptoms but not correct the causes of RA. Novel strategies …

Molecular Peptide Grafting as a Tool to Create Novel Protein Therapeutics

AA Komar - Molecules, 2023 - mdpi.com
The study of peptides (synthetic or corresponding to discrete regions of proteins) has
facilitated the understanding of protein structure–activity relationships. Short peptides can …

A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™

PL Iversen, N Kipshidze, N Kipshidze… - Frontiers in …, 2023 - frontiersin.org
The burden of atherosclerotic cardiovascular disease contributes to a large proportion of
morbidity and mortality, globally. Vaccination against atherosclerosis has been proposed for …

Recombinant KRAS G12D protein vaccines elicit significant anti-tumor effects in mouse CT26 tumor models

Y Wan, Y Zhang, G Wang, PM Mwangi, H Cai… - Frontiers in …, 2020 - frontiersin.org
Drug development targeting the most frequently mutation G12D of KRAS has great
significance. As an attractive immunotherapy, cancer vaccines can overcome binding …

Vaccination therapy for inflammatory bowel disease

Y Liu, F Liao - Human Vaccines & Immunotherapeutics, 2023 - Taylor & Francis
Recently, several novel medications, such as Ustekinumab, Infliximab, and Vedolizumab,
have emerged as potential options for inflammatory bowel disease (IBD) management …

The Immunogenicity and anti-tumor efficacy of a rationally designed neoantigen vaccine for B16F10 mouse melanoma

Y Zhang, Z Lin, Y Wan, H Cai, L Deng, R Li - Frontiers in Immunology, 2019 - frontiersin.org
Tumor neoantigens are ideal targets for cancer immunotherapy as they are recognized by
host immune system as foreigners and can elicit tumor-specific immune responses …